MDLN · NASDAQ · STOCK
Medline Inc.
$35.02
52W $32.81 – $50.88
51/100
$29.63B
40.7
-0.41
Is MDLN Bullish or Bearish?
Mixed.
Innellis AI committee rates Medline Inc. (MDLN) Watch with a composite score of 51/100
, based on 5 analysts with 40% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +9.25 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -10.75 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Value Analyst remains cautious — p/e of 64.1 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.31 across 13 articles, 14d) — News
Bear Case
- P/E of 64.1 is expensive by classic value standards — Value
- Price-to-book of 5.0x prices in significant intangible value — Value
- Price structure making lower highs and lower lows — Technical
- MACD histogram negative -- bearish momentum — Technical
- Trend and market structure agree -- coherent bearish picture — Technical
- Bollinger bandwidth of 24.1% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
51/100
Agreement
40%
Analysts
5
Conviction
Contested
Sector Rank
Top 95%
of 192 Healthcare peers
Value Analyst
bearish
25
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 64.1 is expensive by classic value standards
Technical Analyst
neutral
49
/ 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement
− Price structure making lower highs and lower lows
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 24.1% signals elevated volatility
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
68
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.31 across 13 articles, 14d)
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
37.7
Neutral
MACD Histogram
-0.647
Bearish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Lh Ll
Support
$32.84
Resistance
$43.63
Bollinger %B
0.13
Inside Bands
Price vs Moving Averages
EMA 9
$36.60
Below
EMA 21
$37.89
Below
EMA 50
$38.67
Below
EMA 200
$40.62
Below
Fundamental Analysis
Valuation
61
Profitability
27
Financial Health
85
Cash Flow
70
Valuation
P/E Ratio
40.7×
P/B Ratio
2.60×
PEG Ratio
-1.35
Dividend Yield
0.00%
52W High
$50.88
52W Low
$32.81
Quality & Growth
ROE
1079.4%
ROA
301.2%
Gross Margin
2502.4%
Operating Margin
606.6%
Revenue Growth YoY
—
Debt / Equity
1.09
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 40.7 (rich relative to a 15-40x range); Price-to-book of 2.6x; PEG ratio of -1.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 10.8%; Return on assets of 3.0%; Net margin of 2.3%; Gross margin of 25.0%; Current ratio of 4.33 (healthy short-term liquidity); Debt-to-equity of 1.09; Free cash flow per share is positive (2.36); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full MDLN Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →